The term Traumatic Brain Injury (TBI) refers to a condition in which the brain is injured by outside forces, such as accidents, sports injuries, and, in some circumstances, physical aggression. TBI can have negative psychological and physical effects. Some TBI symptoms show right away after the injury, while others develop gradually. TBI can range from moderate to severe. While a mild TBI may temporarily disrupt brain cells, a severe TBI may result in physical brain damage such bleeding, bruises, and torn tissues. The market for traumatic brain injury therapeutics is expected to develop over the forecast period due to the growing number of pipeline research looking for new TBI treatments. However, a delayed TBI diagnosis could hinder the market for TBI treatments from expanding. The brain develops a hypermetabolic state after a brain injury in an effort to defend itself. This hypermetabolic activity can mask brain damage symptoms, delaying the diagnosis of TBI.
Major Players in the Traumatic Brain Injury Therapeutics Industry:
1.Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company, founded in 1901 and headquartered in Tel Aviv, Israel. It operates in more than 60 countries.
2. Sanofi
Sanofi is a French multinational pharmaceutical and healthcare company, founded in 1973and headquartered in Paris, France. It operates in 192 countries and territories. ALTUVIIIOTM [Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein] once-weekly prophylaxis, a first-in-class, high-sustained factor VIII replacement therapy, was presented today in a late-breaking session at the International Society on Thrombosis and Haemostasis (ISTH) Annual Meeting in Montreal, Canada, in June 2023.
3. Novartis AG
Novartis AG is a Swiss global pharmaceutical firm headquartered in Basel, Switzerland, that was created in 1996. Novartis AG has around 140 partners worldwide. Novartis AG conducted a study in November 2022 to determine the efficacy and safety of several anti-inflammatory medicines in people with moderate cognitive impairment or mild Alzheimer's disease.
4. Pfizer Inc.
Pfizer Inc. Inc is an American multinational pharmaceutical and biotechnology corporation, founded in 1849. The headquarter is in Williamsburgh, New York. It operates to over 181 countries. The Phase 3 TALAPRO-2 study of TALZENNA® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI® (enzalutamide) in men with metastatic castration-resistant prostate cancer (mCRPC), with or without homologous recombination repair (HRR) gene mutations, produced encouraging topline results, according to Pfizer Inc. (NYSE: PFE).
5. Akorn Pharmaceuticals
Akorn Pharmaceuticals was an American generic pharmaceuticals manufacturer, founded in 1971 and headquartered in Lake Forest, Illinois, U.S. It operates in some countries. Akorn shut down all operations on February 22, 2023, filed for bankruptcy once more, and fired hundreds of people.
6. Arbor Pharmaceuticals
Arbor Pharmaceuticals was founded in 2006 and headquartered in Georgia, United States. It operates in Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea and others.
7. F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. commonly known as Roche, is a Swiss multinational healthcare company. It was founded in and headquartered in. It operates in more than 150 countries.
8. Mylan N.V
Mylan N.V was founded in 1961 and headquartered in West Virginia, United States. It operates in more than 165 countries. Mylan N.V. (NASDAQ: MYL) and Revance Therapeutics, Inc. announced a global collaboration and license agreement in February 2018 for a proposed biosimilar of BOTOX® (onabotulinumtoxinA). BOTOX, the market-leading neuromodulator, is approved for use in the United States and other countries for a range of indications.
9. Lupin
Lupin is an Indian multinational pharmaceutical company, founded in 1968 and headquartered in Maharashtra, India. It operates in 11 countries. Atharv Ability, a top-notch neuro-rehabilitation facility, will open in February 2023 at Bandra Kurla Complex (BKC) in Mumbai, India, according to a statement from Lupin Limited (Lupin). The country's first multi-disciplinary robotic and computer-assisted neuro-rehabilitation facility is one of the most cutting-edge rehabilitation facilities.
10. Apotex Inc.
Apotex Inc. was founded in 1974 and headquartered in Canada. It operates in more than 45 countries.
*Definition: A traumatic brain injury (TBI) can result from an object piercing the skull and entering the brain, as well as from a strong bump, blow, or jolt to the head or body. A TBI is not always the consequence of strikes or jolts to the head.Depending on the type of TBI, there may be temporary or short-term issues with a person's ability to think, understand, move, communicate, and act.
